Odd L Gammelgaard

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Mesenchymal Stem Cells

Top Venues

Molecular cancer

Nature communications

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Odd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin, Simone Johansen, Sofie Traynor, Henriette Vever, Per Guldberg, Annette Raskov Kodahl, Morten Frier Gjerstorff, Henrik Jørn Ditzel
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis. Molecular cancer 23 (1) (2024)
Odd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin, Simone Johansen, Sofie Traynor, Henriette Vever, Per Guldberg, Annette Raskov Kodahl, Morten Frier Gjerstorff, Henrik Jørn Ditzel
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis. Molecular cancer 23 (1) (2024)
Odd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin, Simone Johansen, Sofie Traynor, Henriette Vever, Per Guldberg, Annette Raskov Kodahl, Morten Frier Gjerstorff, Henrik Jørn Ditzel
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis. Molecular cancer 23 (1) (2024)
Odd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin, Simone Johansen, Sofie Traynor, Henriette Vever, Per Guldberg, Annette Raskov Kodahl, Morten Frier Gjerstorff, Henrik Jørn Ditzel
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis. Molecular cancer 23 (1) (2024)
Odd L Gammelgaard, Mikkel G Terp, Christian Renn, Aran F Labrijn, Oliver Hamaker, Aaraby Yoheswaran Nielsen, Henriette Vever, Soren Wk Hansen, Morten Frier Gjerstorff, Christa Elisabeth Müller, Paul W H I Parren, Henrik Jørn Ditzel
Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity. Journal for immunotherapy of cancer 10 (9) (2022)
Carla L Alves, Sidse Ehmsen, Mikkel G Terp, Neil Portman, Martina Tuttolomondo, Odd L Gammelgaard, Monique F Hundebøl, Kamila Kaminska, Lene E Johansen, Martin Bak, Gabriella Honeth, Ana Bosch, Elgene Lim, Henrik Jørn Ditzel
Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer. Nature communications 12 (1) (2021)
Carla L Alves, Sidse Ehmsen, Mikkel G Terp, Neil Portman, Martina Tuttolomondo, Odd L Gammelgaard, Monique F Hundebøl, Kamila Kaminska, Lene E Johansen, Martin Bak, Gabriella Honeth, Ana Bosch, Elgene Lim, Henrik Jørn Ditzel
Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer. Nature communications 12 (1) (2021)